Abbott Laboratories is an interesting defensive name after its selloff, offering durability and cash flow despite a mixed earnings history.
Source Post
These 5 Stocks Got Crushed. Are They Now Screaming Buys?
Dividend TalksApr 22, 2026
The creator discusses the recent market rebound, noting that while the broader indexes have recovered, many individual stocks have not. The focus is on identifying potential opportunities among these beaten-down stocks, emphasizing that the market is becoming more selective and rotation is the new momentum trade, rather than a monolithic recovery led by tech.
Linked Mentions
Tickers discussed in this post
Service Now is a compelling buy due to its strong underlying business fundamentals despite a significant stock price drop and multiple compression.
Salesforce's stock has been repriced due to slowing growth and AI narrative complexity, with investors awaiting proof of revenue reaceleration and AI adoption.
Adobe stock is down due to AI fears and disruption concerns, but the business itself is not collapsing, making it an interesting situation to watch.
Nike is a hold as its turnaround is taking longer than expected, with ongoing issues in China and margin pressure.
Linked Signals
Tracked calls opened from this post
NOW
buy opened Apr 22, 2026
-17.75%